Randomized Trial of Biolimus DCB for In-Stent RestenosisRobert A. Byrne, Fernándo Alfonso, Darren Mylotte et al.|JACC: Cardiovascular Interventions|2025Cited by 21
Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM)Robert A. Byrne, Seán Fitzgerald, Fernándo Alfonso et al.|Cardiovascular revascularization medicine|2023Cited by 17
Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trialJean Fajadet, Sigmund Silber, Franz–Josef Neumann et al.|EuroIntervention|2017Cited by 15
9 A prospective, randomized, non-inferiority trial to determine the safety and efficacy of the biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: first-in-man trial (REFORM)Seán Fitzgerald, RA Byrne, BP Traynor et al.|Unknown|2023Cited by 1
TCT-613 A Prospective Randomized Multi-Center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted PatientsJean Fajadet, Simon Elhadad, Eulogio Garcı́a et al.|Journal of the American College of Cardiology|2012Cited by 0